Christobel Selecky, Director at ImmunityBio, Inc. (IBRX), sold 159,478 shares at $9.02 ($1.4M) on 2026-07-01, disclosed to the SEC on 2026-07-06.
Scheduled sale ($1.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IBRX | SELL | 2026-01-21 | $625K | — | Filing → |